Tag: Sonova

All

Latest

Sonova Releases Strong 2021/22 First-half Financial Report

Maintaining the outlook provided at the start of the financial year 2021/22, Sonova expects consolidated sales to increase by 24-28% in 2021/22. Compared to pre-pandemic levels in the first half of the financial year 2019/20, this represents a 2-year compound annual growth rate of 8.5%.

Neuromod Appoints Susan Whichard to Board

Whichard has more than 30 years’ experience in the hearing industry, having worked as both a business executive and a practicing healthcare professional, as a clinical audiologist. Her appointment comes as Neuromod plans continued expansion of the availability of Lenire, its tinnitus treatment device across Europe and in the US, pending FDA approval, according to the company’s announcement.

Read More

Demant A/S Releases 2021 Interim Financial Report

Based on expectations that “its strong business momentum and market share gains in Hearing Healthcare will continue in H2 – despite tailwind from the French reform not recurring to the same extent as in H1 – Demant upgrades its guidance for the Group’s organic growth rate for 2021 to 26-30% (previously 24-28%).”

Read More

Oticon’s Gary Rosenblum Appointed HIA Chair

Elected in the spring of 2017, Brandon Sawalich, President and CEO, Starkey, now hands over the Chairmanship of the Hearing Industries Association (HIA) to Gary Rosenblum, President, Oticon, Inc, HIA announced. The members of HIA elected Rosenblum unanimously to this position.

Read More

Sonova Releases 2021/21 Annual Report

Sonova says that “a sharp dip in activity in April 2020 was followed by a swift recovery, reflecting the market’s strong fundamentals, the successful launch of the Phonak Paradise platform, and Sonova’s strategic growth initiatives.” All three businesses returned to growth in the second half of the financial year, with sales up 6.6% in local currencies.

Read More

Sonova to Acquire Sennheiser Consumer Division

Sonova Holding AG announced that it has signed an agreement to acquire the Consumer Division from Sennheiser electronic GmbH & Co KG (Sennheiser). The Sennheiser Consumer Division, which concentrates on the business of headphones and hearables for private customers, is said to be “an excellent fit with Sonova’s strategy to lead innovation in hearing experience and to engage consumers early on their hearing journey.”

Read More

Sonova to Acquire 3.7% Ownership Stake in Sensorion

Sensorion, a clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, announced that Sonova Holding AG will acquire a 3.7% ownership stake in Sensorion by way of subscription to a reserved share capital increase for total gross proceeds of €5 million (USD $6.08 million).

Read More
Loading